Insulin-like growth factor 1 prevents atherosclerosis progression in aged apolipoprotein E-deficient mice.

被引:0
|
作者
Higashi, Y. [1 ]
Sukhanov, S. [1 ]
Shai, S.-Y. [1 ]
Titterington, J. [1 ]
Delafontaine, P. [1 ]
机构
[1] Tulane Univ, Sch Med, Cardiol Sect, New Orleans, LA 70112 USA
关键词
D O I
10.1097/00042871-200701010-00710
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S279 / S279
页数:1
相关论文
共 50 条
  • [41] Comparison of effect of thiazolidinediones on atherosclerosis in apolipoprotein E-deficient mice
    Miyata, M
    Gong, Q
    Biro, S
    Eto, H
    Orihara, K
    Obata, T
    Minagoe, S
    Tei, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 289A - 289A
  • [42] Deficiency of PXR decreases atherosclerosis in apolipoprotein E-deficient mice
    Zhou, Changcheng
    Sui, Yipeng
    Xu, Jinxian
    Rios-Pilier, Jennifer
    DRUG METABOLISM REVIEWS, 2011, 43 : 169 - 169
  • [43] Inhibition of plasminogen activator inhibitor-1 protects against atherosclerosis progression in apolipoprotein E-deficient mice
    Liu, JJ
    Antrilli, TM
    Elokdah, H
    Hennan, JK
    Crandall, DL
    Fay, WP
    BLOOD, 2003, 102 (11) : 792A - 792A
  • [44] Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice
    Jormsjö, S
    Wuttge, DM
    Sirsjö, A
    Whatling, C
    Hamsten, A
    Stemme, S
    Eriksson, P
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (03): : 939 - 945
  • [45] Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein E-deficient mice
    Hayek, T
    Hamoud, S
    Keidar, S
    Pavlotzky, E
    Coleman, R
    Aviram, M
    Kaplan, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 43 (01) : 140 - 147
  • [46] Overexpression of CCN3 Inhibits Inflammation and Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
    Liu, Jun
    Ren, Yingang
    Kang, Li
    Zhang, Lihua
    PLOS ONE, 2014, 9 (04):
  • [47] Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice
    Veinbergs, I
    Mallory, M
    Sagara, Y
    Masliah, E
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (12) : 4541 - 4546
  • [48] Farnesyltransferase inhibitor, manumycin A, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice
    Sugita, Michiko
    Sugita, Hiroki
    Kaneki, Masao
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : 1390 - 1395
  • [49] Effect of macrophage-derived apolipoprotein E on established atherosclerosis in apolipoprotein E-deficient mice
    Shi, WB
    Wang, XP
    Wang, NJ
    McBride, WH
    Lusis, AJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (10) : 2261 - 2266
  • [50] Ticagrelor Prevents Cardiac Inflammation and Fibrosis in Apolipoprotein E-deficient Mice
    Li, Xiaoyan
    Qu, Caihong
    Lu, Ying
    Zhang, Xiaona
    Xie, Jingwen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C56 - C57